Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates

By Konishi E.   Kurane I.   Mason P.W.   Shope R.E.   Kanesa-Thasan N.   Smucny J.J.   Hoke C.H.   Ennis F.A.  

Vaccine, Vol. 16, Iss. 8, 1998-05 ,pp. : 842-849

Elsevier

Access to resources Recommend Favorite

A purified inactivated Japanese encephalitis virus vaccine made in vero cells

By Srivastava A.K.   Putnak J.R.   Lee S.H.   Hong S.P.   Moon S.B.   Barvir D.A.   Zhao B.   Olson R.A.   Kim S.-O.   Yoo W.-D.   Towle A.C.   Vaughn D.W.   Innis B.L.   Eckels K.H.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4557-4565

Elsevier

Access to resources Recommend Favorite

Cross-protective and infection-enhancing immunity in mice vaccinated against flaviviruses belonging to the Japanese encephalitis virus serocomplex

By Lobigs M.   Pavy M.   Hall R.  

Vaccine, Vol. 21, Iss. 15, 2003-04 ,pp. : 1572-1579

Elsevier

Access to resources Recommend Favorite

Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults

By Zent O.   Beran J.   Jilg W.   Mach T.   Banzhoff A.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 738-741

Elsevier

Access to resources Recommend Favorite

An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2

By Makoschey B.   Janssen M.G.J.   Vrijenhoek M.P.   Korsten J.H.M.   Marel P.v.d.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3261-3268

Elsevier

Access to resources Recommend Favorite